Assessment of liver function in patients with type 2 diabetes receiving ertugliflozin

被引：0
|
作者：
Gallo, S. [1 ]
Calle, R. A. [2 ]
Terra, S. G. [3 ]
Pong, A. [4 ]
Tarasenko, L. [5 ]
Raji, A. [4 ]
机构：
[1] Pfizer Pharma GmbH, Berlin, Germany
[2] Pfizer Inc, Cambridge, MA USA
[3] Pfizer Inc, Andover, MA USA
[4] Merck & Co Inc, Kenilworth, NJ USA
[5] Pfizer Inc, New York, NY USA
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
712
引用
收藏
页码：S341 / S341
页数：1
相关论文
共 50 条
  • [31] EFFECTS OF ERTUGLIFLOZIN ON BLOOD PRESSURE AND PULSE RATE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Liu, Jie
    Pong, Annpey
    Gallo, Silvina
    Darekar, Amanda
    Terra, Steven
    Lauring, Brett
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1810 - 1810
  • [32] Effect of ertugliflozin on renal function and cardiovascular outcomes in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
    Cheng, Qian
    Zou, Shupeng
    Feng, Chengyang
    Xu, Chan
    Zhao, Yazheng
    Shi, Xuan
    Sun, Minghui
    [J]. MEDICINE, 2023, 102 (10) : E33198
  • [33] Ertugliflozin plus metformin as a treatment option for type 2 diabetes
    Athyros, Vasilios G.
    Boutari, Chrysoula
    Karagiannis, Asterios
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (16) : 2105 - 2111
  • [34] Assessment of kidney function in type 2 diabetes
    Chadban, S.
    Howell, M.
    Twigg, S.
    Thomas, M.
    Jerums, G.
    Cass, A.
    Campbell, D.
    Nicholls, K.
    Tong, A.
    Mangos, G.
    Stack, A.
    MacIsaac, R. J.
    Girgis, S.
    Colagiuri, R.
    Colagiuri, S.
    Craig, J.
    [J]. NEPHROLOGY, 2010, 15 : S146 - S161
  • [35] Long-term effects of ertugliflozin (ERTU) on liver enzymes and indices in patients with type 2 diabetes: analyses from VERTIS CV
    Corbin, K. D.
    Dagogo-Jack, S.
    Cannon, C. P.
    Charbonnel, B.
    Cherney, D. Z. I.
    Cosentino, F.
    McGuire, D. K.
    Shih, W. J.
    Frederich, R.
    Liu, J.
    Pong, A.
    Cater, N. B.
    Pratley, R. E.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 218 - 219
  • [36] Effects of pioglitazone on liver function in comparison to gliclazide in patients with type 2 diabetes
    Perriello, G
    Pampanelli, S
    Di Pietro, C
    Brunetti, P
    [J]. DIABETES, 2004, 53 : A141 - A141
  • [37] Improvement of liver function parameters in patients with type 2 diabetes treated with thiazolidinediones
    Ono, M
    Ikegami, H
    Fujisawa, T
    Nojima, K
    Kawabata, Y
    Nishino, M
    Taniguchi, H
    Itoi-Babaya, M
    Babaya, N
    Inoue, K
    Ogihara, T
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (04): : 529 - 532
  • [38] SATISFACTION ASSESSMENT OF CONTINUOUS GLUCOSE MONITORING IN TYPE 2 DIABETES PATIENTS RECEIVING INPATIENT CARE
    Rivas Montenegro, A. M.
    Anez Ramos, R.
    Galdon Sanz-Pastor, A.
    Andia Melero, V.
    Bescos Perez, M.
    Castellanos Rodriguez, A.
    Gonzalez Albarran, O.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A209 - A209
  • [39] Assessment of Motor Function of Phrenic Nerve in Type 2 Diabetes Mellitus Patients
    Sweety, L. M.
    [J]. JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2021, 9 (08): : 124 - 125
  • [40] Assessment of diastolic function in patients with type 2 diabetes mellitus with gated SPECT
    Korkmaz, A.
    Caliskan, B.
    Erdem, F.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S548 - S548
12345